These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21258965)

  • 1. Biochemical, environmental, and genetic factors associated with paraoxonase (PON1) activity.
    Sirivarasai J; Kaojarern S; Sura T; Yoovathaworn K
    Biochem Genet; 2011 Jun; 49(5-6):364-8. PubMed ID: 21258965
    [No Abstract]   [Full Text] [Related]  

  • 2. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
    Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
    Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of paraoxonase activity in healthy adults.
    Boesch-Saadatmandi C; Rimbach G; Schrader C; Kofler BM; Armah CK; Minihane AM
    Mol Nutr Food Res; 2010 Dec; 54(12):1842-50. PubMed ID: 20658496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
    Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
    Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of non-genetic factors on paraoxonase 1 activity in patients undergoing hemodialysis.
    Rajković MG; Rumora L; Juretić D; Grubisić TZ; Flegar-Mestrić Z; Vrkić N; Sinjeri Z; Barisić K
    Clin Biochem; 2010 Dec; 43(18):1375-80. PubMed ID: 20807524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase phenotype distribution in a healthy Iranian population.
    Sepahvand F; Shafiei M; Ghaffari SM; Rahimi-Moghaddam P; Mahmoudian M
    Basic Clin Pharmacol Toxicol; 2007 Aug; 101(2):104-7. PubMed ID: 17651311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
    Bryk B; BenMoyal-Segal L; Podoly E; Livnah O; Eisenkraft A; Luria S; Cohen A; Yehezkelli Y; Hourvitz A; Soreq H
    J Neurochem; 2005 Mar; 92(5):1216-27. PubMed ID: 15715671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of paraoxonase (PON1) activity.
    Costa LG; Vitalone A; Cole TB; Furlong CE
    Biochem Pharmacol; 2005 Feb; 69(4):541-50. PubMed ID: 15670573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human paraoxonase gene polymorphisms and coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
    Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals.
    Schiavon R; Turazzini M; De Fanti E; Battaglia P; Targa L; Del Colle R; Fasolin A; Silvestri M; Biasioli S; Guidi G
    Acta Neurol Scand; 2007 Jul; 116(1):26-30. PubMed ID: 17587252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
    Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
    Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms and activity of PON1 in a Mexican population.
    Rojas-García AE; Solís-Heredia MJ; Piña-Guzmán B; Vega L; López-Carrillo L; Quintanilla-Vega B
    Toxicol Appl Pharmacol; 2005 Jun; 205(3):282-9. PubMed ID: 15922013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease.
    Jarvik GP; Hatsukami TS; Carlson C; Richter RJ; Jampsa R; Brophy VH; Margolin S; Rieder M; Nickerson D; Schellenberg GD; Heagerty PJ; Furlong CE
    Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1465-71. PubMed ID: 12805074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
    Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
    Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between human serum esterases and environmental metal compounds.
    Hernández AF; Gil F; Leno E; López O; Rodrigo L; Pla A
    Neurotoxicology; 2009 Jul; 30(4):628-35. PubMed ID: 19393262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase 1 status and interactions between Q192R functional genotypes by smoking contribute significantly to total plasma radical trapping antioxidant potential.
    Bortolasci CC; Maes M; Vargas HO; Souza-Nogueira A; Moreira EG; Nunes SO; Berk M; Dodd S; Barbosa DS
    Neurosci Lett; 2014 Oct; 581():46-51. PubMed ID: 25153516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides.
    López-Flores I; Lacasaña M; Blanco-Muñoz J; Aguilar-Garduño C; Sanchez-Villegas P; Pérez-Méndez OA; Gamboa-Avila R
    Toxicol Lett; 2009 Jul; 188(2):84-90. PubMed ID: 19446239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance in human paraoxonase-1 gene between phenotypes and genotypes in chronic kidney disease.
    Paragh G; Seres I; Harangi M; Pocsai Z; Asztalos L; Locsey L; Szeles G; Kardos L; Varga E; Karpati I; Adany R
    Nephron Clin Pract; 2009; 113(1):c46-53. PubMed ID: 19602899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
    Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
    Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arylesterase and paraoxonase activity of paraoxonase (PON1) affected by ischemia in the plasma of patients with arterial occlusion of the lower limbs.
    Kasprzak M; Iskra M; Majewski W; Wielkoszyński T
    Clin Biochem; 2009 Jan; 42(1-2):50-6. PubMed ID: 18976644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.